Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

One Biotechnology Stock on Radar Ahead of its H1 FY25 Results - ANP

Aug 07, 2025 | Team Kalkine
One Biotechnology Stock on Radar Ahead of its H1 FY25 Results - ANP
Image source: shutterstock

  • ANP:LSE
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (GBX)

Anpario PLC (LSE: ANP)

Anpario PLC (LSE: ANP) is an FTSE AIM All-listed United Kingdom-based independent manufacturer, specializing in natural and sustainable feed additives for animal health, nutrition, and biosecurity. The company is dedicated to enhancing intestinal health and nutrition in animals, offering feed additive solutions tailored for poultry, ruminants, swine, aquaculture, and feed mills. This Report covers the Investment Highlights, Conclusion, and Recommendation on the stock.

ANP will release its H1 FY25 results on 10 September 2025.

Key Investment Rationale – Speculative Buy at GBX 382.97

  • Encouraging Sales Momentum in Key Regions: Anpario’s first-half performance has been buoyed by notable growth in several international markets. In particular, the United States and India have shown promising sales activity, highlighting the company’s ability to capitalise on targeted business development efforts.
  • Product Diversification Supporting Resilience: The company’s broad portfolio, spanning different species and geographical areas, may provide a level of protection against external uncertainties. This diversity appears well-placed to support steady performance even amid global challenges.
  • New Product Launch Plans Gaining Traction: Preparation to introduce Bio-Vet’s established products into global markets is progressing, with early feedback from stakeholders reportedly positive. The ongoing registration process reflects Anpario’s strategic intent to expand its footprint in high-potential segments.
  • Financial Base for Continued Growth: Despite a modest reduction in cash position, the company maintains a healthy balance sheet. This financial stability could offer flexibility to pursue both organic growth and acquisition opportunities going forward.

ANP Daily Chart & Valuation

For conducting the valuation, the following peers have been considered: Glanbia PLC (LSE: GL9), Kerry Group PLC (LSE: KYGA), and others.

As per the above-mentioned price action, a ‘Speculative Buy’ rating has been given on Anpario PLC (LSE: ANP) at the current Market Price of GBX 382.97, as of August 07, 2025, at 09:35 AM GMT+1.

Markets are trading in a highly volatile zone currently due to certain Macro & Micro-economic data and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 07 August 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’

Note 6: Dividend Yield may vary as per the stock price movement.


Disclaimer-

This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites.  All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.

Past performance is not a reliable indicator of future performance.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions